-
公开(公告)号：US6083960A
公开(公告)日：2000-07-04
申请号：US397355
申请日：1999-09-16
申请人： Michael Ankersen , Florenzio Zaragoza Dorwald , Carsten Enggaard Stidsen , Albert Michael Crider
发明人： Michael Ankersen , Florenzio Zaragoza Dorwald , Carsten Enggaard Stidsen , Albert Michael Crider
IPC分类号： A61K31/44 , A61K31/4439 , A61K31/445 , A61K31/4545 , A61P1/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P11/00 , A61P25/00 , A61P27/02 , A61P43/00 , C07D213/74 , C07D295/194 , C07D401/12 , C07D401/14
CPC分类号： C07D213/74 , C07D401/12 , C07D401/14 , Y10S514/866
摘要： The present invention relates to a compound of general formula I ##STR1## for treating medical disorders related to binding to human somatostatin receptor subtypes.
摘要翻译： 本发明涉及用于治疗与人生长抑素受体亚型结合有关的医学病症的通式I化合物。
-
公开(公告)号：US6020349A
公开(公告)日：2000-02-01
申请号：US962098
申请日：1997-10-31
申请人： Michael Ankersen , Florenzio Zaragoza Dorwald , Carsten Enggaard Stidsen , Albert Michael Crider
发明人： Michael Ankersen , Florenzio Zaragoza Dorwald , Carsten Enggaard Stidsen , Albert Michael Crider
IPC分类号： A61K31/44 , A61K31/4439 , A61K31/445 , A61K31/4545 , A61P1/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P11/00 , A61P25/00 , A61P27/02 , A61P43/00 , C07D213/74 , C07D295/194 , C07D401/12 , C07D401/14 , C07D401/02
CPC分类号： C07D213/74 , C07D401/12 , C07D401/14 , Y10S514/866
摘要： The present invention relates to a compound of general formula I ##STR1## for treating medical disorders related to binding to human somatostatin receptor subtypes.
-
3.发明授权Use of somatostatin agonists and antagonists for treating diseases related to the eye 失效生长抑素激动剂和拮抗剂用于治疗与眼睛有关的疾病
公开(公告)号：US6159941A
公开(公告)日：2000-12-12
申请号：US97907
申请日：1998-06-16
IPC分类号： A61K31/4439 , A61K31/4709 , A61K31/506 , A61K31/5377 , C07D213/74 , C07D401/12 , C07D521/00 , A61K38/00
CPC分类号： C07D213/74 , A61K31/4439 , A61K31/4709 , A61K31/501 , A61K31/506 , A61K31/5377 , C07D231/12 , C07D233/56 , C07D249/08 , C07D401/12 , Y10S514/913
摘要： The invention relates to the use of a somatostatin receptor ligand of nonpeptide origin, e.g. of the general formula Ia or Ib ##STR1## or a pharmaceutically acceptable salt thereof, which has high and/or selective affinity to the somatostatin receptor protein designated SSTR4 and, for the preparation of a medicament for the treatment of a disease associated with an adverse condition in the retina and/or iris-ciliary body of a mammal. Such conditions are high intraocular pressure (IOP) and/or deep ocular infections. The diseases which may be treated are e.g. glaucoma, stromal keratitis, iritis, retinitis, cataract and conjunctivitis.
摘要翻译： 本发明涉及使用非肽来源的生长抑素受体配体，例如， 具有对命名为SSTR4的生长抑素受体蛋白具有高和/或选择性亲和力的通式Ia或Ib或其药学上可接受的盐，并且用于制备用于治疗与不良状况相关的疾病的药物 视网膜和/或虹膜睫状体。 这种情况是高眼内压（IOP）和/或深部眼部感染。 可以治疗的疾病是例如 青光眼，基质角膜炎，虹膜炎，视网膜炎，白内障和结膜炎。
-
公开(公告)号：US20110294729A1
公开(公告)日：2011-12-01
申请号：US13133465
申请日：2009-12-03
摘要： Insulin analogues wherein the B25 amino acid residue is His or Asn with the proviso that if the B25 amino acid residue is His, then the B27 amino acid residue is Asp or Glu and the A14 amino acid residue is different from Glu, have liver preferential actions.
摘要翻译： 胰岛素类似物，其中B25氨基酸残基为His或Asn，条件是如果B25氨基酸残基为His，则B27氨基酸残基为Asp或Glu，A14氨基酸残基与Glu不同，具有肝脏优先作用 。
-
-
-
搜索结果
4 条记录 (耗时 0.019 秒)
